simvastatin has been researched along with Cochlear Hearing Loss in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, C; Cai, Q; Du, X; Kermany, MH; Yoo, T; Zhang, C; Zhou, B | 1 |
| Bodmer, D; Brand, Y; Chavez, E; Levano, S; Listyo, A; Pak, K; Radojevic, V; Ryan, AF; Setz, C; Sung, M | 1 |
2 other study(ies) available for simvastatin and Cochlear Hearing Loss
| Article | Year |
|---|---|
Effects of simvastatin on plasma lipoproteins and hearing loss in apolipoprotein E gene-deficient mice.
Topics: Animals; Anticholesteremic Agents; Apolipoproteins E; Atherosclerosis; Female; Hair Cells, Auditory; Hearing Loss, Sensorineural; Hyperlipidemias; Lipids; Mice; Mice, Inbred C57BL; Mice, Knockout; Severity of Illness Index; Simvastatin | 2009 |
Simvastatin protects auditory hair cells from gentamicin-induced toxicity and activates Akt signaling in vitro.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Gentamicins; Hair Cells, Auditory; Hearing Loss, Sensorineural; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Transgenic; Nerve Degeneration; Neuroprotective Agents; Primary Cell Culture; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; Simvastatin | 2011 |